Prognostic factors for relapse in stage I seminoma: a new nomogram derived from three consecutive, risk-adapted studies from the Spanish Germ Cell Cancer Group (SGCCG).

@article{Aparicio2014PrognosticFF,
  title={Prognostic factors for relapse in stage I seminoma: a new nomogram derived from three consecutive, risk-adapted studies from the Spanish Germ Cell Cancer Group (SGCCG).},
  author={J Aparicio and Pablo Eduardo Romo Maroto and Xavier Garcia del Muro and A. S{\'a}nchez-mu{\~n}oz and Josep Gum{\`a} and M Carmen Margel{\'i} and Alberto S{\'a}enz and Naiara Sagastibelza and Daniel E. Castellano and Jos{\'e} {\'A}ngel Arranz and David Herv{\'a}s and Rom{\'a} Bast{\'u}s and Antonio Fern{\'a}ndez-Aramburo and Javier Sastre and Josefa Terrasa and Marta Francisca L{\'o}pez-Brea and Joan Dorca and Daniel Almenar and Joan Carles and Ang{\'e}lica Victoria Hern{\'a}ndez and Josep Ram{\'o}n Germ{\`a}},
  journal={Annals of oncology : official journal of the European Society for Medical Oncology},
  year={2014},
  volume={25 11},
  pages={
          2173-8
        }
}
BACKGROUND We aimed to analyze prognostic factors for relapse in stage I seminoma managed by either active surveillance or adjuvant chemotherapy, and to describe the long-term patterns of recurrence in both groups. PATIENTS AND METHODS From 1994 to 2008, 744 patients were included in three consecutive, prospective risk-adapted studies by the Spanish Germ Cell Cancer Group. Low-risk patients were managed by surveillance and high-risk patients were given two courses of adjuvant carboplatin… CONTINUE READING
Tweets
This paper has been referenced on Twitter 5 times. VIEW TWEETS

Citations

Publications citing this paper.
SHOWING 1-10 OF 21 CITATIONS

References

Publications referenced by this paper.
SHOWING 1-10 OF 22 REFERENCES

Similar Papers

Loading similar papers…